For many patients, persistent or worsening pain after spine surgery — a condition broadly termed Failed Back Surgery Syndrome (FBSS) — signals that the underlying disc pathology was not fully resolved. In carefully selected candidates, non-surgical options such as intra-annular fibrin injection may help address remaining annular damage, though outcomes vary by individual and prior surgical history.
Understanding Failed Back Surgery Syndrome (FBSS)
FBSS is not a single diagnosis but a general term describing persistent or new back and leg pain that continues after spinal surgery. It is a common and complex challenge in spine care, affecting a meaningful proportion of surgical patients and leaving many in continued or worsened pain.
FBSS may present in several ways, including:
- Persistent pain at or near the surgical site
- New pain in a different spinal region or lower extremity
- Numbness, tingling, or weakness in the legs or feet
- Reduced mobility or functional decline
- Increased reliance on pain medication
Beyond physical discomfort, FBSS frequently contributes to emotional distress, disrupted sleep, depression, and a significantly diminished quality of life. Addressing both the structural and psychological dimensions of ongoing pain is an important component of comprehensive care.
Why Does Spine Surgery Sometimes Fail?
The contributors to FBSS are multifaceted. Understanding them may help patients and their care providers identify more targeted, non-surgical approaches going forward.
Persistent or Recurrent Disc Pathology
A surgery may address a disc herniation without sealing the underlying annular tear that allowed disc material to escape. When the tear remains open, the disc can re-herniate or continue to generate pain through chemical irritation of surrounding nerves. Annular tears are a recognized root cause of chronic low back pain that often goes unaddressed by decompressive surgery alone.
Epidural Fibrosis (Scar Tissue Formation)
After any spinal surgery, the body naturally forms scar tissue. In some patients, epidural fibrosis — scar tissue that encases nerve roots — may cause persistent compression and pain even when the original surgical objective was technically achieved. This complication can be difficult to treat with conventional methods.
Adjacent Segment Disease (ASD)
Spinal fusion immobilizes one or more vertebral segments, transferring increased mechanical stress to the levels immediately above and below the fusion. Over time, this accelerated loading may lead to new disc degeneration, herniation, or stenosis at those adjacent levels — sometimes requiring further intervention. Adjacent segment disease is a well-documented long-term concern following fusion surgery.
Incomplete Decompression or Diagnostic Inaccuracy
In some cases, the surgery may not have fully relieved the affected nerve root, or the primary pain generator may have been misidentified before the procedure. Chronic spinal pain often has multiple overlapping sources, and isolating the most significant contributor is a critical step that is sometimes underestimated.
Surgical Instability
Procedures such as laminectomy or discectomy may occasionally remove enough bone or ligamentous tissue to contribute to subtle segmental instability, creating a new source of ongoing mechanical pain.
Central Sensitization and Psychological Factors
Chronic pain can alter how the nervous system processes pain signals, a phenomenon known as central sensitization. Anxiety, depression, and psychological stress — which frequently accompany prolonged pain — may amplify pain perception and complicate recovery. Comprehensive FBSS care ideally addresses these dimensions alongside structural treatment.
Limitations of Traditional Approaches After Failed Surgery
Patients with FBSS are often guided back to familiar conservative therapies. While these have a role in symptom management, they may fall short when the underlying disc pathology remains unaddressed.
Physical Therapy
Physical therapy is valuable for improving strength, flexibility, and movement mechanics. However, if an active annular tear or significant disc degeneration is the primary pain source, rehabilitative exercise may manage symptoms without resolving the structural issue. Many patients benefit from combining physical therapy with a more targeted disc-level intervention.
Oral Medications
Pain relievers, muscle relaxants, and anti-inflammatory drugs may offer temporary symptom relief, but they do not repair damaged disc tissue. Long-term dependence carries risks of side effects and does not alter the underlying pathology driving the pain.
Epidural Steroid Injections (ESIs)
ESIs may provide short-term reduction in nerve inflammation. Their effectiveness for chronic low back pain, particularly over longer time horizons, is limited for many patients — they reduce inflammation transiently rather than promoting tissue healing or sealing an annular defect. For patients who have already tried ESIs without lasting benefit, a different approach warrants consideration. Learn more about moving beyond epidural injections toward disc-level repair.
Expert Take
When pain persists after surgery and repeated injections, the question worth asking is whether the source of the pain — often an unsealed annular tear — has ever been directly treated. Symptom-management strategies mask the signal; biologic repair attempts to address what is generating it. Candidacy must be evaluated individually, and not every patient with FBSS will be a suitable candidate for disc-level intervention.
A Different Approach: Biologic Disc Repair
Regenerative spine care focuses on repairing damaged disc tissue rather than removing it or immobilizing the segment with fusion. For carefully selected FBSS patients whose pain originates from an active annular tear or residual disc pathology, this biological approach may offer a meaningful path forward where conventional treatments have provided insufficient relief.
Our clinical team specializes in minimally invasive biologic treatments designed to target the root cause of disc-generated pain — the torn annulus — rather than simply managing the downstream symptoms.
Intra-Annular Fibrin Injection: Targeted Annular Tear Repair
Among the most evidence-supported biologic approaches for disc pathology is intra-annular fibrin injection. This fibrin disc treatment targets damaged intervertebral discs with identifiable annular tears — defects in the tough outer fibrous ring (annulus fibrosus) that allow the inner nucleus pulposus to leak, inflame surrounding tissue, and compress nerve roots.
How the Fibrin Procedure Works
Using image guidance, a clinician precisely delivers concentrated fibrin — a natural protein central to tissue repair and blood clotting — directly into the annular tear. Once placed, the fibrin acts as a biological sealant and scaffold through several mechanisms:
- Sealing the Defect: The fibrin matrix forms a flexible seal over the tear, reducing further nuclear material leakage and limiting the release of inflammatory mediators that irritate adjacent nerve roots.
- Providing Structural Scaffolding: The fibrin matrix creates a framework within the disc that may support the natural regeneration of annular fibrocartilage and help restore disc integrity over time.
- Stimulating Healing: Fibrin contains growth factors and signaling proteins that may activate the body’s intrinsic repair pathways, supporting tissue-level healing rather than mere symptom suppression.
The procedure is performed on an outpatient basis, typically under fluoroscopic or discographic guidance with local anesthesia and light sedation. It avoids the tissue disruption, extended recovery, and long-term mechanical consequences associated with open surgery.
What Clinical Evidence Suggests for FBSS Patients
Published research on intra-annular fibrin injection includes data from patients who had already undergone prior spinal surgery without achieving lasting relief. Findings suggest that meaningful pain reduction and functional improvement are achievable in a subset of FBSS candidates, though individual responses vary and outcomes cannot be predicted in advance. Patients who showed identifiable annular pathology on advanced imaging tended to respond more favorably, underscoring the importance of rigorous pre-treatment evaluation.
For a deeper look at the evidence base, see our overview of emerging evidence supporting biologic disc repair.
Are You a Candidate for Biologic Disc Repair After FBSS?
Determining whether intra-annular fibrin injection is appropriate requires thorough individual evaluation. Candidates are assessed on a case-by-case basis; no two post-surgical presentations are the same. Our clinical team conducts a comprehensive workup that typically includes:
- Detailed Surgical and Medical History: A careful review of prior procedures, treatments tried, and current symptom patterns
- Physical and Neurological Examination: Assessment of mobility, strength, reflexes, and sensory function
- Advanced Imaging Review: Recent MRI is essential to identify active annular tears, residual disc pathology, and rule out conditions that would not benefit from fibrin disc treatment — such as severe canal compromise requiring urgent decompression
- Discographic Evaluation (when indicated): Provocation discography may be used to confirm which disc levels are pain-generating before proceeding with treatment
Candidates most likely to be considered for evaluation include those with chronic low back pain or radiculopathy persisting after prior surgery, an identifiable annular tear on imaging, and inadequate relief from conservative measures. Patients with primarily scar-tissue-related nerve entrapment, severe instability, or other structural conditions may require different management pathways.
Use our self-assessment guide to understand whether a candidacy evaluation may be appropriate for your situation.
What to Expect After Annular Tear Repair
Recovery from the fibrin procedure differs significantly from open surgery. Most patients return home the same day and resume light activity within a short period. Because the procedure is minimally invasive, the recovery trajectory is generally far less demanding than revision surgical procedures — though individual timelines vary based on the extent of disc pathology, the number of levels treated, and overall health status.
Healing from annular tear repair occurs gradually as the fibrin scaffold supports tissue regeneration over weeks to months. Many patients begin to notice improvement in pain and function progressively during this period. Our clinical team provides individualized recovery guidance; read more about what recovery after spine treatment may involve.
Considering Your Options After Failed Surgery
Living with persistent pain after spinal surgery is a disorienting and isolating experience. Being told the only remaining options are additional surgery or lifelong pain management is understandably discouraging. For some patients with FBSS, biologic disc repair represents a meaningful alternative worth evaluating — one that addresses the disc-level source of pain without the risks and consequences of further open surgery.
The right next step is not the same for every patient. What matters most is a thorough, honest evaluation of what is actually driving the pain and whether a targeted biologic approach is likely to help in a specific case. Our clinical team is committed to that kind of individualized assessment.
If you would like to explore whether intra-annular fibrin injection may be appropriate for your situation, we invite you to review our related resources: After Failed Back Surgery: Is Biologic Disc Repair Your Next Step? and 5 Things to Know About Avoiding Failed Back Surgery with Regenerative Disc Repair First.
